Innovations in Nanoemulsion Technology: Enhancing Drug Delivery for Oral, Parenteral, and Ophthalmic Applications.

Pharmaceutics · 2024 · PMC11510719 · PMID 39458662

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Additionally, over 60% of the drug was released within the first two hours of the dissolution testing, indicating a highly significant difference ( p < 0.001) in drug release between formulations generated by each approach. 4.1.2.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.